[Immunotropic therapy of rheumatoid arthritis (prerequisites, results and principles)].
The author has summed up many-year investigation and literature data on immunological approaches to RA therapy including a study of the patients' immunological status, evaluation of the clinical efficacy and immunological effects of various therapeutic methods, and a study of the individual sensitivity of drugs in in vitro experiments. An indicator proposed by the author for the evaluation of clinicoimmunological therapeutic efficacy, expresses the true value of the method of RA therapy. Indices of the immune status necessary for a choice of patients and control of immunotropic therapy were defined; methods for the assessment of individual sensitivity to immunoreactive agents and principles of immunotropic therapy were presented.
Benenson
E V
EV
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D001327:Autoimmune Diseases / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007596:Joints / Q000528:radiation effects; D010396:Penicillamine / Q000627:therapeutic use; D000074402:Synovectomy
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D010396:Penicillamine
Immunotropnaia terapiia revmatoidnogo artrita (predposylki, rezul'taty, printsipy).